【New Stock IPO】“Three Little Dragons of AI Pharmaceuticals” Jiantai Technology 7666 over-the-counter session surged to nearly 3.6 times at one point—making 18,750 yuan profit per lot. The allocation results are out: the “A-end” was steady, while some “B-first” missed out.

“One of the ‘Big Three’ AI Pharmaceutical Stocks,” Ji Tai Technology (07666),
listed on May 13th, with dark pool trading after the market closed on Tuesday (12th).
Based on the combined three major trading platforms, Ji Tai’s dark pool initial trading saw a high of HKD 48,
which is 357% higher than the IPO price of HKD 10.5, with a lot of 500 shares earning a paper profit of HKD 18,750.

Brokerages announced the allotment results to investors sequentially on Monday (11th).
However, this time, Ji Tai’s allotment situation was different from usual, with a stable “A group” and some “B group” allocations falling short.
As for the IPO of Ying Pai Pharmaceuticals, initial allotment results were also available.

Sources indicate that applying for 400k shares or 800 lots (about HKD 4.24 million) in the A group
guarantees 1 to 2 lots of allocation, but some “B group” applicants, such as those applying for 500k shares (about HKD 5.3 million)
or 1 million shares (worth about HKD 10.61 million), are not guaranteed to be successful.
As for the “head-tossing” (about HKD 53.35 million), they can receive 3 to 4 lots (1500 to 2000 shares).

Market analysts suggest that, due to the higher number of applicants in the B group for this IPO,
the allocation results may differ from the usual phenomenon where “more applications lead to higher chances of winning.”

The other two companies among the “Big Three” AI Pharmaceutical Stocks are Jing Tai Technology (02228)
and Ying Xi Intelligent (03696).

To follow news on new stocks, visit 【New Stock IPOs】.

Market focus on the “Xi-Trump Meeting” — Will the stock market fully activate?
Will Hong Kong stocks rally again? Or do we still need Alibaba and Tencent’s earnings to drive the market?